Telavancin: A novel lipoglycopeptide antibiotic

E., Damodaran; S., Madhan

doi:10.4103/0976-500X.81918

ArchivesVol. 2 | Issue 2 | 2011 | pp. 135–137Open Access

Telavancin: A novel lipoglycopeptide antibiotic

¹^*,
¹

¹Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry - 605 006, India.

Correspondence: Damodaran E.
Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry - 605 006, India.
Email: damodaran.se@gmail.com

Published: Jan 1, 2011

DOI: https://doi.org/10.4103/0976-500X.81918
Article URL: https://front-journal-woad.vercel.app/article/j-pharmacol-pharmacother-2-2-135
PDF URL: https://front-journal-woad.vercel.app/article/j-pharmacol-pharmacother-2-2-135.pdf

Abstract

No abstract available.

Readers Also Viewed

Original Research Article

Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

Annisa Fatharani, Ali Alsayegh

Jan 1, 2026

Original Research Article

Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia

Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby

Jan 1, 2026

Review Article

Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review

Mohammad Akbar Hossain

Jan 1, 2026